30 December 2023 in Seminars in Medical Writing and Education
Bioprinting is a revolutionary technology in the area of producing organs and tissues in biomedical engineering. Despite potential, variability in bioinks, nonlinear dynamics, and variability in the environment cause precision and reliability in the process. The current methods, such as the Proportional-Integral-Derivative (PID) controller, are plagued with disadvantages such as slow convergence, susceptibility to local minima, and a lack of adaptability in variable conditions. Overcoming these disadvantages, a hybrid system is presented, Scalable Shuffled Shepherd-tuned adaptive PID controller (SSS-Adaptive PID). The Adaptive PID Controller dynamically adapts in real time with variable conditions and guarantees stability and responsiveness. The SSS Optimization maximizes optimization with increased convergence and enhanced robustness and overcomes the issues with time-varying and nonlinear conditions in bioprinting. The results of the experiments are reduced Rise Time (0.21 × 10⁻5 sec), Settling Time (0.05 × 10⁻3 sec) and peak time (0.09 × 10⁻3 sec). Improved cell viability and structure fidelity are also noted in printed constructs. It overcomes the disadvantages to conventional methods and is a consistent and efficient solution in 3D bioprinting. By permitting adaptive and accurate control, the system makes high-quality organs and tissues production possible in biomedical applications.
30 December 2023 in Seminars in Medical Writing and Education
Pharmaceutical marketing plays a crucial role in shaping healthcare practices, influencing both medical professionals and consumers. However, ethical concerns have emerged regarding deceptive advertising, financial incentives for healthcare providers, and the exploitation of vulnerable populations. The objective is to assess how various marketing strategies influence public and healthcare professionals' ethical perceptions of pharmaceutical industry practices and identify areas for improvement in regulatory frameworks. Independent variables include Direct-to-Consumer Advertising (DTCA), Financial Incentives (FI) to healthcare providers, Transparency of Drug Information (TDI), Regulatory Compliance (RC), and Public Trust (PT) in the pharmaceutical industry. The dependent variable is the Ethical Perception of Pharmaceutical Marketing(EPPM),measured by the perceptions of healthcare professionals and patients on the ethical practices in pharmaceutical marketing and their trust in the industry. Data is collected through surveys of 306 healthcare professionals and 216 patients, along with interviews with pharmaceutical executives, using descriptive statistics and regression analysis in SPSS 25. Regression analysis reveals significant correlations between pharmaceutical marketing practices and public trust. Descriptive statistics were performed to identify relationships between revealed varying levels of ethical concerns, particularly related to DTCA and financial incentives. The findings suggest that increased transparency, adherence to regulations, and ethical advertising could improve industry practices and enhance public confidence in pharmaceutical companies.
31 December 2024 in Seminars in Medical Writing and Education
SJSujayaraj Samuel Jayakumar
Sujayaraj Samuel Jayakumar
+1
Medical communication using artificial intelligence (AI) might improve relationships between physicians and patients and provide better outcomes on health. It looks at how consumers and healthcare professionals may interact more easily thanks to AI-powered solutions such virtual assistants and robots. AI technologies may provide physicians accurate, current information, assist in clinical decision-making, reduce their mental load so they may concentrate on more challenging aspects of treatment. Moreover made accessible seven days a week, twenty-four hours a day are artificial intelligence technologies. In this sense, individuals may always acquire customised to their medical requirements answers and assistance. This paper investigates how effectively artificial intelligence technologies could raise patient engagement in medical exchanges, confidence, and pleasure. Examining many artificial intelligence systems used in healthcare reveals how they enable individuals to interact better by addressing shared issues such language and mental stress, and how they assist to solve the shortage of healthcare professionals. Particularly with regard to safeguarding data privacy and maintaining the human touch in healthcare, we also discuss the moral questions and challenges raised by artificial intelligence usage. Particularly how quickly and precisely AI can provide medical advice, assist to reduce the risk of misunderstandings, and enhance treatment commitment, researchers are also investigating how AI influences patient outcomes. The results of the research show that although artificial intelligence is a terrific tool for enhancing doctor-patient communication, it must be utilised wisely so as not to replace human understanding. Better, more knowledgeable, and more compassionate treatment for patients in the future is what we expect to see by supporting AI systems and healthcare professionals to cooperate. This will raise their confidence in the medical system and enhance their general state of wellness.